US2023295643A1PendingUtilityA1

Curing for recursive nucleic acid-guided cell editing

84
Assignee: INSCRIPTA INCPriority: Jun 6, 2019Filed: Mar 13, 2023Published: Sep 21, 2023
Est. expiryJun 6, 2039(~12.9 yrs left)· nominal 20-yr term from priority
C12N 9/22C12N 15/70C12N 15/635C12N 2310/20C12N 15/111C12N 15/113C12N 2800/80
84
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides automated multi-module instrumentation and automated methods for performing recursive editing of live cells with curing of editing vectors from prior rounds of editing.

Claims

exact text as granted — not AI-modified
1 . A composition of matter for recursive nucleic acid-directed nuclease CRISPR editing comprising:
 a first vector comprising:
 an origin of replication; 
 one or more editing gRNA and donor DNA pairs under the control of a first inducible promoter, wherein the editing gRNA and donor DNA pairs edit target sequences in a cell; 
 a curing target sequence, wherein the curing target sequence is cut to cleave the vector; 
 a first selectable marker; and 
   a second vector comprising:
 a second selectable marker; and 
 a curing gRNA sequence under the control of a second inducible promoter, wherein the curing gRNA targets the curing target sequence on the first vector. 
   
     
     
         2 .- 25 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.